|
Primary outcome
|
|
Spectrophotometric hemoglobin (SpHb) at 4 months
|
|
(n = 127/DCC = 65,ECC = 62)
|
12.4
|
(0.8)
|
12.3
|
(0.7)
|
0.1
|
[−0.17, 0.35]
|
0.50
|
|
Secondary outcome
|
|
Anemia (SpHb < 11.0 g/dl) (n = 126/DCC = 64,ECC = 62)
|
1
|
(1.6)
|
0
|
(0.0)
|
1.0
|
[0.95, 1.02]
|
1.00
|
|
Neonatal jaundice
|
|
Total serum bilirubin (TsB) (days 3-5)) a (n = 122/DCC = 63, ECC = 59)
|
12.8
|
(3.5)
|
12.1
|
(3.4)
|
0.7
|
[−0.55, 1.91]
|
0.27
|
|
Over the excess level of transcutaneous bilirubin (TsB) b (n = 122/DCC = 63, ECC = 59)
|
6
|
(9.5)
|
4
|
(6.8)
|
1.4
|
[0.42, 4.73]
|
0.75
|
|
Phototherapy c (n = 123/DCC = 63, ECC = 60)
|
7
|
(11.1)
|
4
|
(6.7)
|
1.7
|
[0.51, 5.40]
|
0.53
|
|
Hematocrit
|
|
Hematocrit level (days 3-5) (%) a (n = 121/DCC = 62, ECC = 59)
|
57.2
|
(5.3)
|
52.5
|
(5.2)
|
4.6
|
[2.74, 6.53]
|
< 0.01*
|
|
High hematocrit (Hct≧65%) (n = 121/DCC = 62, ECC = 59)
|
3
|
(4.6)
|
2
|
(3.0)
|
0.7
|
[0.10, 4.00]
|
0.68
|
